share_log

Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $25

Benzinga ·  Apr 26 08:59

Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $28 to $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment